Translate Bio, Inc.
We are a leading messenger RNA, or mRNA, therapeutics company developing a new class of potentially transformative medicines to treat diseases caused by protein or gene dysfunction
$12.00 - $14.00
Citigroup, Leerink Partners, Evercore ISI
To view the prospectus for Translate Bio, Inc. IPO, or any offering listed on ClickIPO,
download the ClickIPO app...
or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277